The American Hospital Association is once again raising concerns about how a major drugmaker handles the government’s 340B ...

The American Hospital Association (AHA) expresses serious concerns with the recent announcement by Eli Lilly and Company (Lilly) to require 340B covered entities to submit claims data for all ...

The cost of prescription drugs is certain to be a hot-button issue in the coming Illinois legislative session with two separate measures making for curious bedfellows in Springfield.

The 340B drug pricing plan is meant to help low-income patients. It needs better oversight in this state.

On January 15, 2026, President Trump released a one-page health policy framework. Among other things, the document includes calls for ...

Fifty health centers in Massachusetts, which serve a million patients a year, are straining under an "assault" from federal ...

Community health centers that primarily serve low-income patients fear Gov. Bob Ferguson's proposed supplemental budget will hamper their ability to pa ...

FQHCs are community-based health clinics that receive federal funding to provide primary care services in underserved areas, regardless of a patient’s ability to pay. They often serve as a critical ...

Sagebrush Health Services has filed a lawsuit against Amgen, alleging unlawful termination of discounted drug sales under the ...

The American Hospital Association is asking the Trump administration to stop Eli Lilly from enacting a new policy as part of ...

Roche plans to launch Phase 3 studies of its leading obesity candidate this quarter after the drug led to significant weight loss in a mid-stage trial ...

The Centers for Medicare & Medicaid Services yesterday announced 15 drugs under Medicare Parts D and B selected for the third round of price negotiations. Negotiations will occur this year and any ...